BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20504926)

  • 1. Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways.
    Langley WA; Bradley KC; Li ZN; Smith ME; Schnell MJ; Steinhauer DA
    J Virol; 2010 Aug; 84(16):8300-7. PubMed ID: 20504926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.
    Li ZN; Mueller SN; Ye L; Bu Z; Yang C; Ahmed R; Steinhauer DA
    J Virol; 2005 Aug; 79(15):10003-12. PubMed ID: 16014960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.
    Ramirez K; Ditamo Y; Galen JE; Baillie LW; Pasetti MF
    Vaccine; 2010 Aug; 28(37):6065-75. PubMed ID: 20619377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-based prime-boost immunization for rapid vaccination against anthrax.
    McConnell MJ; Hanna PC; Imperiale MJ
    Mol Ther; 2007 Jan; 15(1):203-10. PubMed ID: 17164792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.
    Abboud N; Casadevall A
    Clin Vaccine Immunol; 2008 Jul; 15(7):1115-23. PubMed ID: 18480236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies virus glycoprotein as a carrier for anthrax protective antigen.
    Smith ME; Koser M; Xiao S; Siler C; McGettigan JP; Calkins C; Pomerantz RJ; Dietzschold B; Schnell MJ
    Virology; 2006 Sep; 353(2):344-56. PubMed ID: 16820183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
    Park YS; Lee JH; Hung CF; Wu TC; Kim TW
    Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R; Gupta PK; Banerjea AC; Singh Y
    Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity.
    Pittman PR; Fisher D; Quinn X; Schmader T; Barrera-Oro JG
    Vaccine; 2013 Oct; 31(44):5009-14. PubMed ID: 24026013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine.
    McComb RC; Martchenko M
    Vaccine; 2016 Jan; 34(1):13-9. PubMed ID: 26611201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
    Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR
    Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC; An HJ; Yu YZ; Xu Q
    Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.
    Chi X; Li J; Liu W; Wang X; Yin K; Liu J; Zai X; Li L; Song X; Zhang J; Zhang X; Yin Y; Fu L; Xu J; Yu C; Chen W
    Clin Vaccine Immunol; 2015 May; 22(5):553-60. PubMed ID: 25787135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.
    Reason D; Liberato J; Sun J; Keitel W; Zhou J
    Infect Immun; 2009 May; 77(5):2030-5. PubMed ID: 19223482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Sindbis virus vectors designed to express protective antigen of Bacillus anthracis protect animals from anthrax and display synergy with ciprofloxacin.
    Thomas JM; Moen ST; Gnade BT; Vargas-Inchaustegui DA; Foltz SM; Suarez G; Heidner HW; König R; Chopra AK; Peterson JW
    Clin Vaccine Immunol; 2009 Nov; 16(11):1696-9. PubMed ID: 19759250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of peptides from Bacillus anthracis protective antigen on Tobacco Mosaic Virus as an epitope targeted anthrax vaccine.
    McComb RC; Ho CL; Bradley KA; Grill LK; Martchenko M
    Vaccine; 2015 Nov; 33(48):6745-51. PubMed ID: 26514421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.